Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6  months of age

CONCLUSIONS: The immunogenicity of the HepB surface antigen in the EPI Shan-5 vaccine was similar to that achieved by the hexavalent vaccine, but was higher than that achieved by the Quinvaxem vaccine. The Shan-5 vaccine is highly immunogenic and generates robust antibody responses after primary immunization.PMID:37202270 | DOI:10.1016/j.vaccine.2023.05.014

Source: Vaccine - May 18, 2023 Category: Allergy & Immunology Authors: Nasamon Wanlapakorn Napa Pruetarat Nasiri Sarawanangkoor Kanchana Phanphanit Donchida Srimuan Thaksaporn Thatsanathorn Thanunrat Thongmee Nawarat Posuwan Yong Poovorawan Source Type: research